Skip to main content Accessibility help
×
Home

Vancomycin-Resistant Enterococci in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1999–2005

Published online by Cambridge University Press:  02 January 2015

Marianna Ofner-Agostini
Affiliation:
Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Ottawa, Canada
B. Lynn Johnston
Affiliation:
Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
Andrew E. Simor
Affiliation:
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
John Embil
Affiliation:
Health Sciences Centre, Winnipeg, Manitoba, Canada
Anne Matlow
Affiliation:
Hospital for Sick Children, Toronto, Ontario, Canada
Michael Mulvey
Affiliation:
National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
John Conly
Affiliation:
Foothills Medical Centre, Calgary, Alberta, Canada
Corresponding
E-mail address:

Abstract

Surveillance for vancomycin-resistant enterococci (VRE) in sentinel Canadian hospitals has been conducted since 1999. From 1999 to 2005, the rate of VRE detection increased from 0.37 to 1.32 cases per 1,000 patients admitted, and the rate of VRE infection increased from 0.02 to 0.05 cases per 1,000 patients admitted. Thirty-three percent of all patients with VRE detected that were reported during 1999-2005 were identified in 2005, with increases seen in all regions of Canada. Although the incidence rate of VRE carriage in Canada is increasing, it remains very low.

Type
Concise Communications
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below.

References

1.Chang, S, Sievert, DM, Hageman, JC, et al.Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:12421247.CrossRefGoogle ScholarPubMed
2.Ofner-Agostini, ME, Conly, J, Paton, S, et al.Vancomycin-resistant enterococci (VRE) in Canada—results of the Canadian Nosocomial Infection Surveillance Program 1996: VRE point prevalence surveillance project. Can J Infect Dis 1997;8:7378.CrossRefGoogle ScholarPubMed
3.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1990– May 1999, issued June 1999. Am J Infect Control 1999;27:520532.CrossRefGoogle ScholarPubMed
4.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128140.CrossRefGoogle ScholarPubMed
5.Ofner-Agostini, M, Varia, M, Johnston, L, et al.Infection control and antimicrobial restriction practices for antimicrobial resistant organisms (AROs) in Canadian tertiary care hospitals. Am J Infect Control 2007;35:563568.CrossRefGoogle Scholar
6.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362386.Google ScholarPubMed
7.Simor, AE, Ofner-Agostini, M, Gravel, D, et al.; Canadian Hospital Epidemiology Committee; Canadian Nosocomial Infection Surveillance Program, Public Health Agency of Canada. Surveillance for mefhicillin-resistant Staphylococcus aureus in Canadian hospitals—a report update from the Canadian Nosocomial Infection Surveillance Program. Can Commun Dis Rep 2005;31:3340. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05pdf/cdr3103.pdf. Accessed January 28, 2008.Google Scholar
8.Johnston, BL, Conly, JM. Clostridium difficile: the evolving story. Can J Infect Dis Med Microbiol 2007;18:341345.Google ScholarPubMed
9.Johnston, L, Ofner-Agostini, ME, Holton, D, et al.Laboratory and infection control protocols for vancomycin-resistant enterococci (VRE): a survey of CHEC facilities. In: 67th Conjoint Meeting on Infectious Diseases; October 31–November 4, 1999; Edmonton, Alberta, Canada. Abstract P49.Google Scholar

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 0
Total number of PDF views: 7 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 17th January 2021. This data will be updated every 24 hours.

Hostname: page-component-77fc7d77f9-wd6lz Total loading time: 0.347 Render date: 2021-01-17T09:58:51.026Z Query parameters: { "hasAccess": "0", "openAccess": "0", "isLogged": "0", "lang": "en" } Feature Flags last update: Sun Jan 17 2021 09:52:53 GMT+0000 (Coordinated Universal Time) Feature Flags: { "metrics": true, "metricsAbstractViews": false, "peerReview": true, "crossMark": true, "comments": true, "relatedCommentaries": true, "subject": true, "clr": true, "languageSwitch": true, "figures": false, "newCiteModal": false, "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true }

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Vancomycin-Resistant Enterococci in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1999–2005
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Vancomycin-Resistant Enterococci in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1999–2005
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Vancomycin-Resistant Enterococci in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1999–2005
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *